Staburo at the 70th Biometric Colloquium in Lübeck

Apr 18, 2024
colloquium

With the slogan “Navigating the Sea of Data: Biometrics Guides the Way”, the 70th Biometric Colloquium took place at the University of Lübeck from February 28 – March 01, 2024.

While various topics were presented, Maria Stark, Senior Data Scientist at Staburo GmbH, delved into practical aspects of planning and analyzing diagnostic studies in the “Statistics in Practice” invited session.

The talk was a joint work together with her former colleagues of Universitätsklinikum Hamburg Eppendorf. They covered several aspects such as the choice of a study design, definition of an estimand, calculation of the sample size and the analysis and report of the study results.

The conference was a successful event, featuring three keynote presentations on statistical methods in high-dimensional genetic data, insights in the work at the European Medicines Agency and causal inference.

This memorable experience for our colleague, Maria Stark, was concluded with a networking dinner hosted at the venue of the traditional restaurant “Schiffergesellschaft,” followed by a guided city tour of Lübeck.

More Articles

7th Staburo Health Data Science Summit 

7th Staburo Health Data Science Summit 

The 7th Staburo Health Data Science Summit brought together experts from the pharmaceutical and life sciences industries to explore the evolving role of biomarkers and data science in advancing precision medicine.  With contributions from leading organizations,...

read more
Staburo @ ISCB/GMDS Conference 2026

Staburo @ ISCB/GMDS Conference 2026

Staburo Team Selected to Present at ISCB/GMDS Conference 2026 We are pleased to share that Maria Stark, Senior Data Scientist, and the team representing Staburo in the GMDS Biostatistics Competition have been selected to present their work at the upcoming ISCB/GMDS...

read more
Biomarkers at Staburo

Biomarkers at Staburo

In 2024 at Staburo was about building momentum in the area Biomarkers. Deepening our engagement in the PSI Biomarker SIG, strengthening collaborations, and developing the ideas that would later become deliverables. In 2025, we developed and released ShadowVIMP, an R...

read more